Pediatric non-cycling PROM1+ cells were further classified according to the expression of other putative glioma stem cells marker such as SOX2 and OLIG2: 54% expressed both markers, 32% only SOX2, 6% only OLIG2, and 8% neither (Fig. 1e, right). This evidence concerns the gene OLIG2 and central nervous system cancer.